Sabra Health Care REIT Statistics
Total Valuation
SBRA has a market cap or net worth of $4.26 billion. The enterprise value is $6.62 billion.
Important Dates
The last earnings date was Monday, May 5, 2025, after market close.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | May 16, 2025 |
Share Statistics
SBRA has 237.94 million shares outstanding. The number of shares has increased by 1.90% in one year.
| Current Share Class | 237.94M |
| Shares Outstanding | 237.94M |
| Shares Change (YoY) | +1.90% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 1.11% |
| Owned by Institutions (%) | 97.87% |
| Float | 235.22M |
Valuation Ratios
The trailing PE ratio is 29.90 and the forward PE ratio is 24.82. SBRA's PEG ratio is 2.72.
| Price/FFO Ratio | 12.78 |
| Price/AFFO Ratio | n/a |
| PE Ratio | 29.90 |
| Forward PE | 24.82 |
| PS Ratio | 5.84 |
| Forward PS | 5.63 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 1.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 12.60 |
| PEG Ratio | 2.72 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 47.05 |
| EV / Sales | 9.20 |
| EV / EBITDA | 15.33 |
| EV / EBIT | 24.83 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.89.
| Current Ratio | 0.85 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | 5.55 |
| Debt / FCF | n/a |
| Interest Coverage | 2.35 |
Financial Efficiency
Return on equity (ROE) is 5.15% and return on invested capital (ROIC) is 3.22%.
| Return on Equity (ROE) | 5.15% |
| Return on Assets (ROA) | 3.14% |
| Return on Invested Capital (ROIC) | 3.22% |
| Return on Capital Employed (ROCE) | 5.20% |
| Revenue Per Employee | $14.40M |
| Profits Per Employee | $2.82M |
| Employee Count | 50 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SBRA has paid $965,000 in taxes.
| Income Tax | 965,000 |
| Effective Tax Rate | 0.68% |
Stock Price Statistics
The stock price has increased by +23.19% in the last 52 weeks. The beta is 0.85, so SBRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +23.19% |
| 50-Day Moving Average | 17.40 |
| 200-Day Moving Average | 17.49 |
| Relative Strength Index (RSI) | 54.47 |
| Average Volume (20 Days) | 2,414,234 |
Short Selling Information
The latest short interest is 18.58 million, so 7.81% of the outstanding shares have been sold short.
| Short Interest | 18.58M |
| Short Previous Month | 19.10M |
| Short % of Shares Out | 7.81% |
| Short % of Float | 7.90% |
| Short Ratio (days to cover) | 6.94 |
Income Statement
In the last 12 months, SBRA had revenue of $720.25 million and earned $140.76 million in profits. Earnings per share was $0.60.
| Revenue | 720.25M |
| Gross Profit | 487.83M |
| Operating Income | 266.72M |
| Pretax Income | 54.12M |
| Net Income | 140.76M |
| EBITDA | 432.05M |
| EBIT | 266.72M |
| Earnings Per Share (EPS) | $0.60 |
Full Income StatementBalance Sheet
The company has $37.89 million in cash and $2.40 billion in debt, giving a net cash position of -$2.36 billion or -$9.94 per share.
| Cash & Cash Equivalents | 37.89M |
| Total Debt | 2.40B |
| Net Cash | -2.36B |
| Net Cash Per Share | -$9.94 |
| Equity (Book Value) | 2.70B |
| Book Value Per Share | 11.36 |
| Working Capital | -15.97M |
Full Balance SheetCash Flow
| Operating Cash Flow | 338.01M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 67.73%, with operating and profit margins of 37.03% and 19.54%.
| Gross Margin | 67.73% |
| Operating Margin | 37.03% |
| Pretax Margin | 19.68% |
| Profit Margin | 19.54% |
| EBITDA Margin | 59.99% |
| EBIT Margin | 37.03% |
| FCF Margin | n/a |